pharma · Mantle Cell Lymphoma · Colon cancer
Telethon Foundation
Fondazione Telethon ETS
Fondazione Telethon ETS is a pharma organization headquartered in EU. Primary therapeutic focus areas include Mantle Cell Lymphoma, Colon cancer, colorectal cancer, NSCLC non-small cell lung cancer, Follicular lymphoma.
roma, IT HQ
1990 Founded
343 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- roma, IT
- Founded
- 1990
- Employees
- 343
- Programs
- 162
- Drugs
- 285
- Patents
- 0
SMILE
Phase 2 · small molecule · Subjects at high risk of inflammatory state and mortality from lung cancer, other cancers and all causes
SMILE for Subjects at high risk of inflammatory state and mortality from lung cancer, other cancers and all causes is a Phase 2 program (small_molecule) at Fondazione Telethon ETS with 1 ClinicalTrials.gov record(s).
Internal code SMILE
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Fondazione Telethon ETS
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Subjects at high risk of inflammatory state and mortality from lung cancer, other cancers and all causes
- Status
- active
- Trials
- 1